Epidermolysis Bullosa Studies & Clinical Trials
Alfred T. Lane, MD., on EB Research
- Gene Transfer Study for RDEB
- Characteristics of Dystrophic Epidermolysis Bullosa
- Epidermolysis Bullosa Clinical Research Consortium (EBCRC) Study
- NK-1 Receptor Antagonist for the Treatment of Itch in Epidermolysis Bullosa (EB) Patients
- A Phase 3 Study of SD-101 Cream in Patients with Epidermolysis Bullosa
- Autologous Fibroblast Study for RDEB